𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells

✍ Scribed by Jian-ping Zou; Jun Shimizu; Kazuhiro Ikegame; Hidekazu Takiuchi; Hiromi Fujiwara; Toshiyuki Hamaoka


Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
751 KB
Volume
35
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Antigen-presenting cells pulsed with unf
✍ Smita K. Nair; David Boczkowski; David Snyder; Eli Gilboa πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 920 KB

Vaccination with peptides isolated from tumor cells circumvents the need for identifying specific tumor rejection antigens and extends the use of active immunotherapy to the majority of cancers where specific tumor antigens have not yet been identified. In this study, we examined the efficacy of tum

Recognition of tumor glycans by antigen-
✍ Corlien A Aarnoudse; Juan J GarcΓ­a Vallejo; EirΓ­kur Saeland; Yvette van Kooyk πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 367 KB

C-type lectin receptors on antigen-presenting cells are potent antigen-uptake receptors with specificity for glycan structures. Glycosylation changes during malignant transformation create tumor-specific carbohydrate structures that interact with C-type lectins on dendritic cells. Recent findings re

Regression of tumors in mice vaccinated
✍ Smita K. Nair; David Snyder; Barry T. Rouse; Eli Gilboa πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 211 KB πŸ‘ 2 views

Vaccination with tumor extracts circumvents the need to identify specific tumor rejection antigens and extends the use of active immunotherapy to the vast majority of cancers, in which specific tumor antigens have not yet been identified. In this study we examined the efficacy of tumor vaccines comp